0001144204-19-030586.txt : 20190611 0001144204-19-030586.hdr.sgml : 20190611 20190611165950 ACCESSION NUMBER: 0001144204-19-030586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190607 FILED AS OF DATE: 20190611 DATE AS OF CHANGE: 20190611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chan Phillip P. CENTRAL INDEX KEY: 0001442786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36792 FILM NUMBER: 19891543 MAIL ADDRESS: STREET 1: 1001 BRIGGS ROAD STREET 2: SUITE 280 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cytosorbents Corp CENTRAL INDEX KEY: 0001175151 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980373793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE K CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 973-329-8885 MAIL ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE K CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: MedaSorb Technologies CORP DATE OF NAME CHANGE: 20060807 FORMER COMPANY: FORMER CONFORMED NAME: GILDER ENTERPRISES INC DATE OF NAME CHANGE: 20020611 4 1 tv523396_4.xml OWNERSHIP DOCUMENT X0306 4 2019-06-07 0 0001175151 Cytosorbents Corp CTSO 0001442786 Chan Phillip P. C/O CYTOSORBENTS CORPORATION 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852 1 1 0 0 President and CEO Common Stock 2019-06-07 4 M 0 20000 4.325 A 515582 D Stock Option (right to buy) 4.325 2019-06-07 4 M 0 20000 0 D 2020-01-04 Common Stock 20000 0 D Includes (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control," as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 10,300 RSUs granted on March 15, 2018, (b) 18,700 RSUs granted on February 24, 2017, (c) 57,000 RSUs granted on June 7, 2016 and (d) 130,000 RSUs granted on April 8, 2015, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 14,334 RSUs granted on February 28, 2018 which are unvested as of the date hereof and (b) 3,667 RSUs granted on March 4, 2019 and (iii) 281,581 shares of common stock owned by the reporting person, including the 20,000 shares reported on this Form 4. The stock options became fully exercisable on January 4, 2014. /s/ Kathleen P. Bloch attorney-in-fact For Phillip P. Chan 2019-06-11